We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
-2.2%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$8.93B
AUM Growth
-$427M
Cap. Flow
-$6.66M
Cap. Flow %
-0.07%
Top 10 Hldgs %
46.19%
Holding
665
New
38
Increased
95
Reduced
216
Closed
58

Top Buys

Rank Stock Value
1
VLTO icon
Veralto
VLTO
+$53.6M
2
PAYC icon
Paycom
PAYC
+$43.1M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$21.4M
4
FDS icon
Factset
FDS
+$15.8M
5
VEEV icon
Veeva Systems
VEEV
+$13.5M

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$33.8M
2
IQV icon
IQVIA
IQV
+$17.1M
3
MA icon
Mastercard
MA
+$13M
4
DIS icon
Walt Disney
DIS
+$10.7M
5
PYPL icon
PayPal
PYPL
+$10.1M

Sector Composition

Rank Sector Weight
1 Technology 38.33%
2 Healthcare 16.32%
3 Consumer Discretionary 10.8%
4 Financials 10.77%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OXY.WS icon
426
Occidental Petroleum Corp Warrants
OXY.WS
$33.6B
– –
0
– –
VLO icon
427
Valero Energy
VLO
$97.7B
$45.1K ﹤0.01%
350
– –
CATC
428
DELISTED
CAMBRIDGE BANCORP
CATC
$44.7K ﹤0.01%
805
– –
MRNA icon
429
Moderna
MRNA
$25.2B
$43.5K ﹤0.01%
610
+490
+408% +$54.7K
AME icon
430
Ametek
AME
$59B
$43.1K ﹤0.01%
300
– –
VBR icon
431
Vanguard Morningstar Small-Cap Value ETF
VBR
$38.2B
$43K ﹤0.01%
275
– –
IBB icon
432
iShares Biotechnology ETF
IBB
$9.8B
$42.9K ﹤0.01%
367
– –
KIM icon
433
Kimco Realty
KIM
$16.3B
$42.6K ﹤0.01%
2,301
– –
BAX icon
434
Baxter International
BAX
$14B
$42K ﹤0.01%
1,225
– –
TD icon
435
Toronto Dominion Bank
TD
$204B
$41.7K ﹤0.01%
718
-200
-22% -$12.5K
DVY icon
436
iShares Select Dividend ETF
DVY
$23.9B
$41.3K ﹤0.01%
384
– –
FNCL icon
437
Fidelity MSCI Financials Index ETF
FNCL
$2.43B
$41.1K ﹤0.01%
881
– –
KHC icon
438
Kraft Heinz
KHC
$29.8B
$40.8K ﹤0.01%
1,218
– –
ASHR icon
439
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.59B
$37.9K ﹤0.01%
1,527
– –
VTRS icon
440
Viatris
VTRS
$18.7B
$37.9K ﹤0.01%
4,243
– –
DGX icon
441
Quest Diagnostics
DGX
$26.1B
$37.8K ﹤0.01%
288
– –
RGLD icon
442
Royal Gold
RGLD
$19.2B
$37.3K ﹤0.01%
350
– –
EXC icon
443
Exelon
EXC
$46.9B
$36.6K ﹤0.01%
900
– –
OZK icon
444
Bank OZK
OZK
$5.72B
$35.9K ﹤0.01%
930
– –
LBTYK icon
445
Liberty Global Class C
LBTYK
$3.45B
$35.5K ﹤0.01%
2,093
-1,000
-32% -$19.2K
C icon
446
Citigroup
C
$233B
$35.1K ﹤0.01%
850
-2,200
-72% -$96.6K
THG icon
447
Hanover Insurance
THG
$7.74B
$35K ﹤0.01%
300
– –
ZBH icon
448
Zimmer Biomet
ZBH
$18.8B
$34.2K ﹤0.01%
310
-21
-6% -$2.67K
O icon
449
Realty Income
O
$59.8B
$33.3K ﹤0.01%
666
– –
OGN icon
450
Organon & Co
OGN
$3.6B
$33.3K ﹤0.01%
2,538
– –
16 17
18
19 20

Similar funds

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $9.78B AUM 28.72% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Loring Wolcott & Coolidge Fiduciary Advisors held 665 positions worth $8.93B, down 4.6% from $9.36B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q3 2023 filing shows 38 new, 95 increased, 216 reduced and 58 closed positions. Its largest new stake was Veralto: 643,236 shares worth $45.2M. The largest sale was Edwards Lifesciences, an estimated $33.8M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q3 2023 buy was Veralto: 643,236 shares worth $45.2M.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Paycom in Q3 2023, an estimated $43.1M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q3 2023 reduction was Edwards Lifesciences, cutting an estimated $33.8M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited iShares 1-3 Year Treasury Bond ETF in Q3 2023, selling an estimated $574K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 46% of its $8.93B portfolio in Q3 2023.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 38 new positions and closed 58 in Q3 2023.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value fell 4.6% quarter-over-quarter to $8.93B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.